Risk Factors and Diagnostic Model Construction of Chronic Pain with Cognitive Impairment
Changteng Zhang,Ying Su,Xianzheng Zeng,Xiaoyu Zhu,Rui Gao,Wangyang Liu,Runzi Du,Chan Chen,Jin Liu
DOI: https://doi.org/10.2147/jpr.s485000
IF: 2.8319
2024-12-17
Journal of Pain Research
Abstract:Changteng Zhang, 1, 2, &ast Ying Su, 1, 2, &ast Xianzheng Zeng, 3 Xiaoyu Zhu, 1, 2 Rui Gao, 1, 2 Wangyang Liu, 1, 2 Runzi Du, 1, 2 Chan Chen, 1, 2 Jin Liu 1, 2 1 Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China; 2 The Research Units of West China (2018RU012)-Chinese Academy of Medical Sciences, West China Hospital, Sichuan University, Chengdu, People's Republic of China; 3 Department of Pain Management, West China Hospital, Sichuan University, Chengdu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chan Chen, Email ; Background: Cognitive impairment (CI) is frequently observed in patients with chronic pain (CP). CP progression increases the risk of dementia and accelerates Alzheimer's disease pathogenesis. However, risk diagnostic models and biomarkers for CP-related CI remain insufficient. Previous research has highlighted the relationships between several complete blood count parameters for CP or CI-related diseases, such as Alzheimer's disease, while the specific values of complete blood count parameters in CP-related CI patients remain unclear. This study aimed to explore the correlation between complete blood count parameters and CP-related CI to establish a risk diagnostic model for the early detection of CP-related CI. Methods: This cross-sectional study was conducted at West China Hospital, Sichuan University. The Montreal Cognitive Assessment (MoCA) was used to classify patients into either the CP with CI group or the CP without CI group. Univariate analysis and multivariate logistic regression analysis were used to screen the related factors of CP-related CI for constructing a risk diagnostic model, and the model was evaluated using receiver operating characteristic (ROC) curve analysis. Results: The study ultimately included 163 eligible patients. Based on analysis, age (OR, 1.037 [95% CI, 1.007– 1.070]; P =0.018), duration of pain (OR, 2.546 [95% CI, 1.099– 6.129]; P =0.032), VAS score (OR, 1.724 [95% CI, 0.819– 3.672]; P =0.153), LMR (OR, 0.091 [95% CI, 0.024– 0.275]; P < 0.001), absolute neutrophil value (OR, 0.306 [95% CI, 0.115– 0.767]; P =0.014), and lymphocyte percentage (OR, 6.551 [95% CI, 2.143– 25.039]; P =0.002) were identified as critical factors of CP-related CI. The diagnostic model was evaluated by the ROC curve, demonstrating good diagnostic value with an area under the curve (AUC) of 0.803, a sensitivity of 0.603 and a specificity of 0.871. Conclusion: The risk diagnostic model developed in this study for CP-related CI has significant value and enables clinicians to customize interventions based on each patient's needs. Keywords: cognitive impairment, chronic pain, diagnostic model, complete blood count parameters, risk factors Chronic pain (CP) refers to pain that lasts or recurs for more than 3 months. 1 Cognitive impairment (CI) is a prevalent complication in CP patients, primarily characterized by diminished memory, attention, and executive function. 2 CP affects approximately 53% of the communities in the United States, 3 and persistence of pain interference is associated with 21% increased odds of CI for every 2 years. 4 CP persistent progression can increase the risk of Alzheimer's disease (AD) and accelerate AD pathogenesis, 5,6 leading to reduced quality of life, medical adherence, and work capacity for patients. 5 Of note, another meta-analysis have demonstrated that the prevalence of CP in AD patients was as high as 45.8%. 7 A study of CP patients found that two-thirds had impaired working memory and attention. 8 Cognitive function did not improve even after short-term local analgesia, 8 indicating a close bidirectional relationship rather than two separate conditions. The specific mechanisms underlying CP-related CI remain incompletely understood. Current evidence suggests that the two conditions share several common pathophysiological changes. 5 CP and cognitive task execution involve overlapping brain regions, suggesting that pain may reduce the availability of cognitive resources within specific circuits. 5,9 Additionally, abnormalities in the locus coeruleus norepinephrine system, 10 microglial activation and increased central neuroinflammation have been observed in both CP and AD. 11 However, since the unclear mechanisms underlying CP-related CI, effective ris -Abstract Truncated-
clinical neurology